CMV-Independent Lysis of Glioblastoma by Ex Vivo Expanded/Activated Vδ1+ γδ T Cells

Human Vdelta1 gamma-delta T cells exert potent specific cytotoxicity against primary multiple myeloma cells

(2012) Andrea Knight et al.   CYTOTHERAPY

DNA fingerprinting of glioma cell lines and considerations on similarity measurements

(2012) P. Bady et al.   NEURO-ONCOLOGY

Inhibition of NKG2D expression in NK cells by cytokines secreted in response to human cytomegalovirus infection

(2010) A. Muntasell et al.   BLOOD

The role of V 2-negative    T cells during cytomegalovirus reactivation in recipients of allogeneic stem cell transplantation

(2010) A. Knight et al.   BLOOD

Intracellular Sequestration of the NKG2D Ligand ULBP3 by Human Cytomegalovirus

(2010) N. J. Bennett et al.   JOURNAL OF IMMUNOLOGY

Preclinical evaluation of ex vivo expanded/activated γδ T cells for immunotherapy of glioblastoma multiforme

(2010) Nichole L. Bryant et al.   JOURNAL OF NEURO-ONCOLOGY

U87MG Decoded: The Genomic Sequence of a Cytogenetically Aberrant Human Cancer Cell Line

(2010) Michael James Clark et al.   PLoS Genetics

γδ T cells as immune effectors against high-grade gliomas

(2009) Lawrence S. Lamb   IMMUNOLOGIC RESEARCH

Characterization and immunotherapeutic potential of γδ T-cells in patients with glioblastoma

(2009) Nichole L. Bryant et al.   NEURO-ONCOLOGY

Detection of human cytomegalovirus in different histological types of gliomas

(2008) Michael E. Scheurer et al.   ACTA NEUROPATHOLOGICA

Long-term expansion of effector/memory V 2-    T cells is a specific blood signature of CMV infection

(2008) V. Pitard et al.   BLOOD

Immune Response of Human Propagated γδ-T-Cells to Neuroblastoma Recommend the Vδ1+ Subset for γδ-T-cell–based Immunotherapy

(2008) Karin Schilbach et al.   JOURNAL OF IMMUNOTHERAPY

Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma

(2007) Duane A. Mitchell et al.   NEURO-ONCOLOGY